Genomind Partners With NeuroFlow, Transforming Model Of Care For Mental Health Consumers

Genomind®, a leading mental health care company, and NeuroFlow, a health care analytics and technology company, announced an agreement to partner their proprietary technology and clinical services to improve consumer care across a broad spectrum of mental health conditions. The collaboration will leverage NeuroFlow’s industry-leading mental health integration platform alongside Genomind Professional PGx Express™, one of the most comprehensive mental health pharmacogenomics service available. This novel partnership creates a new standard in mental health care by providing consumers and clinicians with actionable tools that support access to care, improve outcomes, and reduce costs in mental health treatment.

As . . .